Phase 3
Completed N=30
A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
Supra-ventricular Tachycardia
Source: ClinicalTrials.gov NCT04392362 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration — 13; 4 participants — p=0.8982
◆ Published Evidence
Highly cited
430citations · ~15 / year
Paroxysmal supraventricular tachycardia in the general population.
Summary
Study to compare non inferiority of giving adenosine with the simplified method vs the AHA method
Linked Publications
-
Paroxysmal supraventricular tachycardia in the general population.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration |
13; 4 | 0.8982 |
Eligibility Criteria
Inclusion Criteria
- Svt
- normal blood pressure
- normal mentation
- Give consent
Exclusion Criteria
- recent coffee
- Allergy to adenosine
- Asthma
- cardiac operations
Data sourced from ClinicalTrials.gov (NCT04392362) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.